Dr. Bormann has served on our Board of Directors since August 2013. In addition, Dr. Bormann has served on our Compensation Committee since 2022. Dr. Bormann currently serves as the Vice President of Translational Science and Network Alliances at The Jackson Laboratory, a nonprofit organization focused on the genetic basis of disease. Dr. Bormann was previously the Chief Executive Officer of Supportive Therapeutics, LLC, a Boston-based company that is developing two molecules for use in the supportive care of oncology patients. In the past several years, Dr. Bormann has held executive positions in several biotechnology companies, including NanoMedical Systems (Austin, Texas), Harbour Antibodies (Rotterdam, The Netherlands), and Pivot Pharmaceuticals (PVTF: OTC listed). Prior to these engagements, Dr. Bormann was Senior Vice President, responsible for worldwide alliances, licensing, and business development at Boehringer Ingelheim Pharmaceuticals, Inc. from 2007 to 2013. From 1996 to 2007, she served in a number of positions at Pfizer, Inc., the last one being Vice President of Pfizer Global Research and Development and worldwide Head of Strategic Alliances. Dr. Bormann serves on the Board of Directors of various companies, including Supportive Therapeutics, LLC, and the Institute for Pediatric Innovation. Dr. Bormann received her PhD in biomedical science from the University of Connecticut Health Center and her BSc from Fairfield University in biology. Dr. Bormann completed postdoctoral training at Yale Medical School in the department of pathology.